Laurus Labs Share Price Analysis, Target, Stock Future Price Prediction
We are analysing the prospects of Laurus labs which is also getting benefitted in the coronavirus scenario as we see that the stock has risen phenomenally from its lows during the lockdown period and how it has regained its lost price in less than 6 months.
Laurus Labs is an Indian pharmaceutical company headquartered in Hyderabad. Its focus areas include active pharma ingredients, finished dosage forms, synthesis, and biotechnology. Laurus Labs manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA.
Have a look at Laurus labs stock chart below and we see the stock scaling to 350,375,400 levels provided the level of 340 is sustained.
The above targets are based on technical chart analysis and fundamentally we see it getting benefitted courtesy of its superior execution in the ARV segment, strong chemistry skill set, which is driving the CDMO business, and addition of new molecules in the other API segments and cost efficiency aiding profitability are the key reasons which will drive its growth profitability.
Get accurate intraday stock tips or Bank Nifty option tips and start making money like professional traders in the Indian stock market as in present times, it is always better to have a second stream of income activated.
You
should Trade Less But Trade Accurately & this is Achieved with our Tip.
